Ashish Kacholia’s stock, specializing in the manufacturing of specialty chemicals jumped upto 3 percent after its Board of Directors approved a 1:2 stock split and the record date is yet to be decided by the Board.
Price action
With a market capitalization of Rs. 9,406.53 crores on Monday, the shares of Ami Organics Limited jumped upto 2.4 percent making a high of Rs. 2297.95 per share compared to its previous closing price of Rs. 2242.15 per share.
What Happened
Ami Organics Limited is in focus after the Board of Directors approved a 1:2 stock split. The decision involves subdividing the existing equity shares with a face value of Rs. 10/- each into two shares of Rs. 5/- each. The record date for the share split will be decided after shareholder approval.
Ace Investor
Ace Investor Ashish Kacholia holds a stake of 1.84 percent in the company which consists of 7,54,974 equity shares as of December, 2024
Ami Organics — At a Glance
Ami Organics is a leading Research and Development manufacturer of Specialty Chemicals, that focuses on the development and manufacturing of Advanced Pharmaceutical Intermediates and Specialty Chemicals, it Serves diverse end-use industries including Pharmaceuticals, Cosmetics, Fine Chemicals, Semiconductor, Battery Chemicals, among others.
Earnings & Business Highlights (Q3FY25)
The company’s EBITA is up by 159 percent YoY to Rs. 68.7 crores, EBITDA Margin to 25 percent and PAT is up by 155 percent YoY to Rs. 45.4 crores, PAT Margin to 16.5 percent up 582 bps YoY and 130 bps QoQ, along with its company’s export revenue for the quarter is 76 percent and Domestic business at 24 percent.
Revenue Segments
The company’s Revenue is driven by two segments of which 79 percent of revenue is from Advanced Pharmaceutical Intermediates and 21 percent of revenue from Specialty Chemicals.
Financials
The company’s total revenue rose by 62.8 percent from Rs. 169.93 crores to Rs. 276.66 crores in Q3FY24-25. Meanwhile, Net profit rose from Rs. 16.75 crores to Rs. 44.95 crores during the same period.
Written by Sridhar J
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses
